Literature DB >> 12537695

Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis.

Bernd Echtenacher1, Daniela N Männel.   

Abstract

Pretreatment of mice with low quantities of LPS induces endotoxin tolerance characterized by enhanced resistance to lethal doses of LPS and to a number of infectious challenges. Mice subjected to cecal ligation and puncture (CLP) survived the ensuing septic peritonitis significantly better when they had been pretreated with LPS. This LPS-induced protection was dependent on endogenous TNF production capacity since LPS pretreatment did not protect TNF-deficient mice from death after CLP. While mice deficient in the TNF receptor type 2 (p75TNFR) were as sensitive to CLP-induced mortality as control mice, LPS pretreatment could not reduce mortality in p75TNFR-deficient mice after CLP. Therefore, activation of the TNF receptor type 2 by endogenous TNF constitutes an important interaction for the development of LPS-induced resistance to bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537695     DOI: 10.1179/096805102125000696

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  14 in total

1.  Implantation of alloplastic material increases survival of mice subsequently exposed to polymicrobial sepsis.

Authors:  Wolfram Kessler; Tobias Ebker; Pia Koerner; Christian Poetschke; Katharina Cziupka; Tobias Traeger; Alexandra Westerholt; Hendrik Mehmcke; Friederike Neher; Robert S Jack; Claus-Dieter Heidecke; Stefan Maier
Journal:  Langenbecks Arch Surg       Date:  2009-01-27       Impact factor: 3.445

Review 2.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

3.  Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation.

Authors:  Mauricio Rosas-Ballina; Sergio I Valdés-Ferrer; Meghan E Dancho; Mahendar Ochani; David Katz; Kai Fan Cheng; Peder S Olofsson; Sangeeta S Chavan; Yousef Al-Abed; Kevin J Tracey; Valentin A Pavlov
Journal:  Brain Behav Immun       Date:  2014-07-23       Impact factor: 7.217

4.  LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock.

Authors:  Ruiming Chang; Yingyan Wang; Jianxing Chang; Liqiang Wen; Zhipeng Jiang; Tao Yang; Kai Yu
Journal:  Inflamm Res       Date:  2014-05-20       Impact factor: 4.575

5.  Divergence of protection induced by bacterial products and sepsis-induced immune suppression.

Authors:  Theo Sterns; Nils Pollak; Bernd Echtenacher; Daniela N Männel
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex.

Authors:  Shoichiro Ohta; Uleng Bahrun; Rintaro Shimazu; Hidetomo Matsushita; Kenji Fukudome; Masao Kimoto
Journal:  Clin Vaccine Immunol       Date:  2006-10

7.  The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.

Authors:  Amit Srivastava; Philipp Henneke; Alberto Visintin; Sarah C Morse; Victoria Martin; Claire Watkins; James C Paton; Michael R Wessels; Douglas T Golenbock; Richard Malley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  Endotoxin increases ascorbate recycling and concentration in mouse liver.

Authors:  Shiu-Ming Kuo; Chee-Ho Tan; Magdalena Dragan; John X Wilson
Journal:  J Nutr       Date:  2005-10       Impact factor: 4.798

9.  Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Authors:  Michaela Windbichler; Bernd Echtenacher; Thomas Hehlgans; Jens C Jensenius; Wilhelm Schwaeble; Daniela N Männel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following gram-negative bacterial infection.

Authors:  Mingfang Lu; Alan W Varley; Shoichiro Ohta; John Hardwick; Robert S Munford
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.